Search company, investor...

Founded Year

1996

Stage

Unattributed | Alive

Total Raised

$760M

Valuation

$0000 

Last Raised

$255M | 2 yrs ago

About Novotech

Novotech operates as a regional full-service contract research organization (CRO). The company provides clinical development services across all clinical trial phases and therapeutic areas including feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, and project and vendor management. It primarily serves the healthcare sector. The company was founded in 1996 and is based in Pyrmont, Australia.

Headquarters Location

235 Pyrmont Street Level 3

Pyrmont, New South Wales, 2090,

Australia

61 (0)2 8569 1400

Loading...

Loading...

Novotech Patents

Novotech has filed 1 patent.

The 3 most popular patent topics include:

  • 3d computer graphics
  • 3d rendering
  • computer display standards
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/18/2020

Computer display standards, 3D rendering, Computer graphic techniques, Video cards, 3D computer graphics

Application

Application Date

12/18/2020

Grant Date

Title

Related Topics

Computer display standards, 3D rendering, Computer graphic techniques, Video cards, 3D computer graphics

Status

Application

Latest Novotech News

Thickins ups the star quotient in Coogee PE giant General Atlantic nabs KKR director Kiwi classifieds giant Trade Me in bankers’...

Feb 12, 2024

Share Joel Thickins’ whereabouts is the talk of the private equity community. But we’ve got the scoop. Street Talk can reveal Thickins, who is managing partner for TPG Asia and head of Australia and New Zealand, has made Coogee in Sydney his new home, moving his family up from Melbourne. Thickins intends to run the firm from his solo Sydney-base, with sources kiboshing suggestions he was poised to open a Sydney office. Thickins is understood to have retained his Melbourne residence and will become a regular commuter of one of the world’s busiest flight paths . He also plays a major role regionally and internationally for TPG so could be based anywhere, the sources added. TPG’s golden boy Joel Thickins (left) with principal Dan Lehav. AFR Thickins is yet to hire a dealmaker to run the new strategy, although sources suggested an operative may be shipped in from offshore. Either way, it’s Thickins’ baby and he’s expected to play a key role for the fund, which will write cheques between $75 million and $150 million and target consumer, technology/software and healthcare companies. Advertisement Melbourne is home to TPG’s Australian and New Zealand headquarters, hosting 20 employees including newly crowned partner and key Thickins lieutenant Vincent Wong. Wong was featured on The Australian Financial Review’s Private Capital Dealmakers list for 2023, and is widely regarded as an expert executor. Investors reckon he was instrumental in making Novotech and Greencross among the most successful deals for TPG Asia. TPG had a good year in 2023, sweeping funeral services business InvoCare off the ASX in what was one of the few take-privates during the year. Its attempt to offload its pets & vets business Greencross to EBOS collapsed at the last minute due to investor caution for funding the acquisition but may be reinvigorated in coming months. 2024 is shaping up to be a big year for TPG, which will look to sell its clinical research business Novotech to a deep-pocketed strategic. TPG has mandated Goldman Sachs to explore options for the business, and added Jefferies Australia to the sell-side team last month. A sale process is slated to get under way in the first half of this year. Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com Kanika Sood is a journalist based in Sydney who writes for the Street Talk column. Email Kanika at kanika.sood@afr.com.au Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review. Connect with Emma on Twitter . Email Emma at emma.rapaport@afr.com Save

Novotech Frequently Asked Questions (FAQ)

  • When was Novotech founded?

    Novotech was founded in 1996.

  • Where is Novotech's headquarters?

    Novotech's headquarters is located at 235 Pyrmont Street , Pyrmont.

  • What is Novotech's latest funding round?

    Novotech's latest funding round is Unattributed.

  • How much did Novotech raise?

    Novotech raised a total of $760M.

  • Who are the investors of Novotech?

    Investors of Novotech include Sequoia Capital, GIC, PPC, TPG Capital, Mercury Capital Partners and 3 more.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.